JEMJOINT "DIACEREIN 50mg. IP + GLUCOSAMINE 750mg. IP + METHYL SULPHONYL METHANE 250mg. IP

Jemjoint tablets reduce knee osteoarthritis pain and stiffness and support cartilage in the joint. Main uses: relief of pain and stiffness in osteoarthritis of the knee; reduction of joint inflammation, swelling and tenderness; improvement of joint movement and daily function in knee osteoarthritis; support of cartilage health in worn knee joints.

Common side effects of Jemjoint Tablet include diarrhoea or loose motions; abdominal pain or cramps; nausea, heartburn or gas; yellowish-brown discolouration of urine (usually harmless); headache; skin rash or itching. Get medical help at once if you notice severe or persistent diarrhoea with fluid loss; yellowing of the skin or eyes, dark urine or pain in the upper abdomen (liver reaction); serious allergic reaction with swelling of the face, lips or tongue and breathing difficulty.

Each Jemjoint tablet contains Diacerein 50 mg + Glucosamine 750 mg + Methyl Sulphonyl Methane 250 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Jemjoint Tablet only as your doctor advises.

The MRP of Jemjoint Tablet is ₹216 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹164.57 and the PTS is ₹148.11.

Each Jemjoint tablet contains Diacerein 50 mg + Glucosamine 750 mg + Methyl Sulphonyl Methane 250 mg. It comes in a pack of 10x10 (Alu Alu).

The medicine works through three roles in the joint. Diacerein curbs the inflammatory chemicals produced inside a worn knee, reducing pain and stiffness. Glucosamine supplies what cartilage and joint fluid are made from and so helps the cushioning layer of the joint. Methyl Sulphonyl Methane provides sulphur for joint tissue and helps maintain joint comfort during movement.

Must not be used by anyone allergic to diacerein, glucosamine, methyl sulphonyl methane or any other ingredient of the tablet. Must not be used in severe kidney disease. Must not be used in patients with current or previous liver disease. Must not be used in children and adolescents below 18 years of age. Must not be used during pregnancy and breastfeeding, or in patients with inflammatory bowel disease, intestinal obstruction, unexplained rectal bleeding or a history of these problems.

Jemjoint Tablet is a brand of Vibcare Pharma, sold through its Auspin division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.